WILMINGTON, Del., Nov. 28, 2016 -- Navient (Nasdaq:NAVI), the nation’s leading loan management, servicing and asset recovery company, today announced that President and CEO Jack Remondi will speak at the Goldman Sachs U.S. Financial Services Conference 2016 on Tuesday, Dec. 6. Remondi will deliver remarks at 8:05 a.m. EST in New York City. A live audio webcast, along with any written materials or slides used during the presentation, will be available at navient.com/investors. A replay will be available approximately two hours following the presentation through Dec. 20.
About Navient
As the nation’s leading loan management, servicing and asset recovery company, Navient (Nasdaq:NAVI) helps customers navigate the path to financial success. Servicing more than $300 billion in student loans, the company supports the educational and economic achievements of more than 12 million Americans. A growing number of public and private clients rely on Navient for proven solutions to meet their financial goals. Learn more at navient.com.
Contact: Media: Patricia Nash Christel, 302-283-4076, [email protected] Investors: Joe Fisher, 302-283-4075, [email protected] Customers: 888-272-5543


Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 



